NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+3.32%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$4.46B
AUM Growth
+$4.46B
Cap. Flow
+$927M
Cap. Flow %
20.81%
Top 10 Hldgs %
62.58%
Holding
61
New
4
Increased
2
Reduced
4
Closed
3

Top Buys

1
COUR icon
Coursera
COUR
$952M
2
MILE
Metromile, Inc. Common Stock
MILE
$96.6M
3
SVRA icon
Savara
SVRA
$50.2M
4
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$17.7M
5
VTGN icon
VistaGen Therapeutics
VTGN
$14.8M

Top Sells

1
PANW icon
Palo Alto Networks
PANW
$95.5M
2
SPT icon
Sprout Social
SPT
$89.2M
3
DZSI
DZS Inc. Common Stock
DZSI
$14.3M
4
SENS icon
Senseonics Holdings
SENS
$9.97M
5
AFMD
Affimed
AFMD
$5.7M

Sector Composition

1 Healthcare 52.55%
2 Consumer Staples 21.37%
3 Industrials 10.31%
4 Technology 6.37%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRNA
26
Verona Pharma
VRNA
$9.18B
$42.7M 0.96%
5,108,563
– –
GRTX
27
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$38.5M 0.86%
4,362,986
– –
BE icon
28
Bloom Energy
BE
$12.3B
$36.1M 0.81%
1,333,333
– –
VTGN icon
29
VistaGen Therapeutics
VTGN
$113M
$34.7M 0.78%
16,302,596
+6,942,596
+74% +$14.8M
ELVN icon
30
Enliven Therapeutics
ELVN
$1.24B
$33.9M 0.76%
4,017,170
– –
MEIP icon
31
MEI Pharma
MEIP
$149M
$29.3M 0.66%
8,533,072
– –
AVEO
32
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$28.9M 0.65%
3,952,958
– –
TCON
33
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$28.5M 0.64%
346,718
– –
GNCA
34
DELISTED
Genocea Biosciences, Inc.
GNCA
$28.1M 0.63%
10,376,936
– –
CBIO
35
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$27.4M 0.61%
9,089,041
– –
MRKR icon
36
Marker Therapeutics
MRKR
$11.2M
$24M 0.54%
10,714,285
+5,714,285
+114% +$12.8M
PHAS
37
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$23M 0.52%
6,643,704
– –
GERN icon
38
Geron
GERN
$893M
$21.3M 0.48%
13,461,538
– –
CTIC
39
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$20.8M 0.47%
7,140,450
– –
CSBR icon
40
Champions Oncology
CSBR
$95.8M
$19.4M 0.43%
1,713,720
– –
MTCR
41
DELISTED
Metacrine, Inc. Common Stock
MTCR
$19M 0.43%
3,062,977
– –
XENE icon
42
Xenon Pharmaceuticals
XENE
$2.99B
$17.8M 0.4%
992,107
– –
STSA
43
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$17.7M 0.4%
+2,997,682
New +$17.7M
TRVI icon
44
Trevi Therapeutics
TRVI
$871M
$16.1M 0.36%
5,940,796
– –
IVA
45
Inventiva
IVA
$802M
$15.3M 0.34%
1,041,666
– –
SYBX icon
46
Synlogic
SYBX
$17.4M
$15.1M 0.34%
4,229,410
– –
OBSV
47
DELISTED
ObsEva SA Ordinary Shares
OBSV
$14.9M 0.33%
4,586,563
– –
LXRX icon
48
Lexicon Pharmaceuticals
LXRX
$392M
$14M 0.31%
2,382,286
– –
SBBP
49
DELISTED
Strongbridge Biopharma plc.
SBBP
$11.4M 0.26%
4,141,308
– –
RGLS
50
DELISTED
Regulus Therapeutics
RGLS
$10.1M 0.23%
6,451,056
– –
1
2
3